EUVIMEDEUVIMED entdecken
Delphi-Studie

Developing Meaningful Score Differences for the Bayley-4 and Vineland-3 in Angelman Syndrome Using a Delphi Panel

Sonya Powers, Katherine N Anderson, Wen-Hann Tan, Julian Tillmann, Mark Daniel, Audrey Thurm, Cristan Farmer, Susanne Clinch, Anne C Wheeler, Anjali Sadhwani, Angelman Syndrome Meaningful Change Delphi Working Group

Value in Health · 2026-10 · 29 (10) · 1781-1790

DOI: 10.1016/j.jval.2025.11.021 ↗

Kurz gefasst

Delphi-Studie in der Zeitschrift Value in Health, 2026-10. Verfasst von Sonya Powers und 10 weiteren Autor:innen. Beteiligte Einrichtung: RTI International, Research Triangle Park, NC, USA; Edmentum, Minneapolis, MN, USA. Hauptthemen laut MEDLINE: Angelman Syndrome, Quality of Life, Caregivers, Child Development. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: FDA HHS, NICHD NIH HHS, National Institute of Child Health and Human Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: This study aimed to develop within-patient meaningful score differences (MSDs) on the Bayley Scales of Infant Development, Fourth Edition (Bayley-4), and the Vineland Adaptive Behavior Scales, Third Edition (Vineland-3), for individuals with Angelman syndrome (AS). METHODS: A Delphi method, involving a panel of 19 caregivers of individuals with AS, was used to establish MSDs for Bayley-4 and Vineland-3 growth scale values. MSD was defined as the smallest change that would noticeably affect the daily functioning of an individual with AS or family quality of life in a way that was important to the individual with AS or their family. For each subscale of the Bayley-4 and Vineland-3, the panel was presented with 2 to 4 vignettes describing varying levels of baseline functioning and asked to select an MSD from a range of potential values. An iterative process involving 3 rounds of ratings and 2 rounds of discussion was used to build consensus. The median caregiver rating from round 3 was retained as the final recommended MSD value for each vignette. RESULTS: Final MSD ratings for the 5 subscales of Bayley-4 and 10 subscales of the Vineland-3 had an agreement rate of 70% or higher. MSD thresholds for each subscale were not single cutoffs, but rather reflected a range of MSD values dependent on the level of baseline functioning. CONCLUSIONS: The Delphi panel method incorporates the caregiver perspective to provide preliminary estimates of what constitutes meaningful within-person change on the Bayley-4 and Vineland-3 in individuals with AS with various levels of baseline functioning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angelman SyndromeQuality of LifeCaregiversChild DevelopmentHumansDelphi TechniqueFemaleMaleInfantChild, PreschoolChildAdaptation, PsychologicalAdult

Stichwörter der Autor:innen

Angelman syndromeclinical outcome assessmentmeaningful change

Autor:innen und Institutionen

  • RTI International, Research Triangle Park, NC, USA; Edmentum, Minneapolis, MN, USA.
  • Division of Genetics and Genomics, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • F. Hofmann-La Roche Ltd, Basel, Switzerland.
  • Mark Daniel Services, Blaine, MN, USA.
  • Neurodevelopmental and Behavioral Phenotyping Service, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
  • RTI International, Research Triangle Park, NC, USA.

Förderung

  • FDA HHS
  • NICHD NIH HHS
  • National Institute of Child Health and Human Development
  • US Food and Drug Administration
  • National Institutes of Health
  • Foundation for Angelman Syndrome Therapeutics
  • Angelman Syndrome Foundation

Zitieren

APA

Powers, S., Anderson, K. N., Tan, W. H., Tillmann, J., Daniel, M., Thurm, A., Farmer, C., Clinch, S., Wheeler, A. C., Sadhwani, A., & Angelman Syndrome Meaningful Change Delphi Working Group (2026). Developing Meaningful Score Differences for the Bayley-4 and Vineland-3 in Angelman Syndrome Using a Delphi Panel. Value in Health, 29(10), 1781-1790. https://doi.org/10.1016/j.jval.2025.11.021

Vancouver

Powers S, Anderson KN, Tan WH, Tillmann J, Daniel M, Thurm A, et al. Developing Meaningful Score Differences for the Bayley-4 and Vineland-3 in Angelman Syndrome Using a Delphi Panel. Value in Health. 2026;29(10):1781-1790. doi:10.1016/j.jval.2025.11.021

BibTeX
@article{Powers2026,
  author = {Powers, Sonya and Anderson, Katherine N and Tan, Wen-Hann and Tillmann, Julian and Daniel, Mark and Thurm, Audrey and Farmer, Cristan and Clinch, Susanne and Wheeler, Anne C and Sadhwani, Anjali and Angelman Syndrome Meaningful Change Delphi Working Group, Angelman Syndrome Meaningful Change Delphi Working Group},
  title = {Developing Meaningful Score Differences for the Bayley-4 and Vineland-3 in Angelman Syndrome Using a Delphi Panel},
  journal = {Value in Health},
  year = {2026},
  volume = {29},
  number = {10},
  pages = {1781--1790},
  doi = {10.1016/j.jval.2025.11.021}
}
Kostenlos starten →